Impact of fluconazole prophylaxis on cortisol levels in critically ill surgical patients

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 7, 2004, Pages 2471-2476

  Magill, Shelley S ^a   Puthanakit, Thanyawee ^a   Swoboda, Sandra M ^a   Carson, Kathryn A ^a   Salvatori, Roberto ^a   Lipsett, Pamela A ^a   Hendrix, Craig W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLUCONAZOLE; HYDROCORTISONE; METHYLPREDNISOLONE; PLACEBO; PREDNISONE;

ADRENAL DISEASE; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; PEROPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; TREATMENT OUTCOME;

ADRENAL GLAND DISEASES; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; CANDIDIASIS; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; FEMALE; FLUCONAZOLE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; SURGICAL PROCEDURES, OPERATIVE;

EID: 3042666082     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.7.2471-2476.2004     Document Type: Article

References (49)

1. Albert, S. G., M. J. DeLeon, and A. B. Silverberg. 2001. Possible association between high-dose fluconazole and adrenal insufficiency in critically ill patients. Crit. Care Med. 29:668-670.
2. Annane, D., V. Sébille, C. Charpentier, P. E. Bollaert, B. François, J. M. Korach, G. Capellier, Y. Cohen, E. Azoulay, G. Troche, P. Chaumet-Riffaut, and E. Bellissant. 2002. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871.
3. Barquist, E., and O. Kirton. 1997. Adrenal insufficiency in the surgical intensive care unit patient. J. Trauma 42:27-31.
4. Beshuizen, A., and L. G. Thijs. 2001. Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Practice Res. Clin. Endocrinol. Metab. 15:513-531.
5. Blumberg, H. M., W. R. Jarvis, J. M. Soucie, J. E. Edwards, J. E. Patterson, M. A. Pfaller, M. S. Rangel-Frausto, M. G. Rinaldi, L. Saiman, R. T. Wiblin, R. P. Wenzel, et al. 2001. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin. Infect. Dis. 33:177-186.
6. Chang, S. S., S. J. Liaw, M. J. Bullard, T. F. Chiu, J. C. Chen, and H. C. Liao. 2001. Adrenal insufficiency in critically ill emergency department patients: a Taiwan preliminary study. Acad. Emerg. Med. 8:761-764.
7. Cooper, M. S., and P. M. Stewart. 2003. Corticosteroid insufficiency in acutely ill patients. N. Engl. J. Med. 348:727-734.
8. de Jong, F. H., C. Mallios, C. Jansen, P. A. Scheck, and S. W. Lamberts. 1984. Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation. J. Clin. Endocrinol. Metab. 59:1143-1147.
9. Dimopoulou, I., I. Ilias, P. Roussou, A. Gavala, A. Malefaki, E. Milou, M. Pitaridis, and C. Roussos. 2002. Adrenal function in non-septic long-stay critically ill patients: evaluation with the low-dose (1 mcg) corticotropin stimulation test. Intensive Care Med. 28:1168-1171.
10. Eckhoff, C., W. Oelkers, and V. Bahr. 1988. Effects of two oral antimycotics, ketoconazole and fluconazole, upon steroidogenesis in rat adrenal cells in vitro. J. Steroid Biochem. 31:819-823.
11. Eggimann, P., P. Francioli, J. Bille, R. Schneider, M. M. Wu, G. Chapuis, R. Chiolero, A. Pannatier, J. Schilling, S. Geroulanos, M. P. Glauser, and T. Calandra. 1999. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit. Care Med. 27:1066-1072.
12. Fridkin, S. K., and R. P. Gaynes. 1999. Antimicrobial resistance in intensive care units. Clin. Chest Med. 20:303-316.
13. Garbino, J., D. P. Lew, J. A. Romand, S. Hugonnet, R. Auckenthaler, and D. Pittet. 2002. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med.28:1708-1717.
14. Georgopapadakou, N. H. 1998. Antifungals: mechanism of action and resistance, established and novel drugs. Curr. Opin. Microbiol. 1:547-557.
15. Goodman, J. L., D. J. Winston, R. A. Greenfield, P. H. Chandrasekar, B. Fox, H. Kaizer, R. K. Shadduck, T. C. Shea, P. Stiff, and D. J. Friedman. 1992. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. 326:845-851.
16. Gradon, J. D., and D. V. Sepkowitz. 1991. Fluconazole-associated acute adrenal insufficiency. Postgrad. Med. J. 67:1084-1085.
17. Kaufman, D., R. Boyle, K. C. Hazen, J. T. Patrie, M. Robinson, and L. G. Donowitz. 2001. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N. Engl. J. Med. 345:1660-1666.
18. Khosla, S., J. S. Wolfson, Z. Demerjian, and J. E. Godine. 1989. Adrenal crisis in the setting of high-dose ketoconazole therapy. Arch. Intern. Med. 149:802-804.
19. Kley, H. K., R. Schlaghecke, and H. L. Krüskemper. 1985. Stabilität von Steroiden im Plasma über einen zeitraum von 10 jahren. J. Clin. Chem. Clin. Biochem. 23:875-878.
20. Lamberts, S. W. J., H. A. Bruining, and F. H. de Jong. 1997. Corticosteroid therapy in severe illness. N. Engl. J. Med. 337:1285-1292.
21. Lebrun-Vignes, B., V. C. Archer, B. Diquet, J. C. Levron, O. Chosidow, A. J. Puech, and D. Warot. 2001. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. Br. J. Clin. Pharmacol. 51:443-450.
22. Leleu, G., P. Aegerter, B. Guidet, et al. 2002. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J. Crit. Care 17:168-175.
23. Liang, K. Y., and S. L. Zeger. 1993. Regression analysis for correlated data. Annu. Rev. Public Health 14:43-68.
24. Ligtenberg, J. J. M., A. R. J. Girbes, J. A. M. Beentjes, J. E. Tulleken, T. S. van der Werf, and J. G. Zijlstra. 2001. Hormones in the critically ill patient: to intervene or not to intervene? Intensive Care Med. 27:1567-1577.
25. Loisa, P., T. Rinne, and S. Kaukinen. 2002. Adrenocortical function and multiple organ failure in severe sepsis. Acta Anaesthesiol. Scand. 46:145-151.
26. Loose, D. S., P. B. Kan, M. A. Hirst, R. A. Marcus, and D. Feldman. 1983. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J. Clin. Investig. 71:1495-1499.
27. Lupetti, A., R. Danesi, M. Campa, M. Del Tacca, and S. Kelly. 2002. Molecular basis of resistance to azole antifungals. Trends Mol. Med. 8:76-81.
28. Marik, P. E., and G. P. Zaloga. 2002. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 122:1784-1796.
29. Michaelis, G., D. Zeiler, J. Biscoping, R. Füssle, and G. Hempelmann. 1993. Function of the adrenal cortex during therapy with fluconazole in intensive care patients. Mycoses 36:117-123.
30. Nagai, K., I. Miyamori, M. Ikeda, H. Koshida, R. Takeda, K. Suhara, and M. Katagiri. 1986. Effect of ketoconazole (an imidazole antimycotic agent) and other inhibitors of steroidogenesis on cytochrome P450-catalyzed reactions. J. Steroid Biochem. 24:321-323.
31. Pelz, R. K., C. W. Hendrix, S. M. Swoboda, M. Diener-West, W. G. Merz, J. Hammond, and P. A. Lipsett. 2001. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann. Surg. 233:542-548.
32. Phillips, P., J. R. Graybill, R. Fetchick, and J. F. Dunn. 1987. Adrenal response to corticotropin during therapy with itraconazole. Antimicrob. Agents Chemother. 31:647-649.
33. Pont, A., J. R. Graybill, P. C. Craven, J. N. Galgiani, W. E. Dismukes, R. E. Reitz, and D. A. Stevens. 1984. High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch. Intern. Med. 144:2150-2153.
34. Pont, A., P. L. Williams, D. S. Loose, D. Feldman, R. E. Reitz, C. Bochra, and D. A. Stevens. 1982. Ketoconazole blocks adrenal steroid synthesis. Ann. Intern. Med. 97:370-372.
35. Rivers, E. P., M. Gaspari, G. Abi Saad, M. Mlynarek, J. Fath, H. M. Horst, and J. Wortsman. 2001. Adrenal insufficiency in high-risk surgical ICU patients. Chest 119:889-896.
36. Rydvall, A., A. K. Brändström, R. Banga, K. Asplund, U. Bäcklund, and B. G. Stegmayr. 2000. Plasma cortisol is often decreased in patients treated in an intensive care unit. Intensive Care Med.26:545-551.
37. Schurmeyer, T., and E. Nieschlag. 1984. Effect of ketoconazole and other imidazole fungicides on testosterone biosynthesis. Acta Endocrinol. (Copenhagen) 105:275-280.
38. Shibata, S., M. Kami, Y. Kanda, U. Machida, H. Iwata, Y. Kishi, A. Takeshita, S. Miyakoshi, J. Ueyama, S. Morinaga, and Y. Mutou. 2001. Acute adrenal failure associated with fluconazole after administration of high-dose cyclophosphamide. Am. J. Hematol. 66:303-305.
39. Slavin, M. A., B. Osborne, R. Adams, M. J. Levenstein, H. G. Schoch, A. R. Feldman, J. D. Meyers, and R. A. Bowden. 1995. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study. J. Infect. Dis. 171:1545-1552.
40. Soni, A., G. M. Pepper, P. M. Wyrwinski, N. E. Ramirez, R. Simon, T. Pina, H. Gruenspan, and C. E. Vaca. 1995. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. Am. J. Med. 98:266-271.
41. Streeten, D. H. 1999. What test for hypothalamic-pituitary-adrenocortical insufficiency? Lancet 354:179-180.
42. Tiao, G. M., J. Martin, F. L. Weber, R. M. Cohen, and D. W. Hanto. 1999. Addisonian crisis in a liver transplant patient due to fluconazole withdrawal. Clin. Transplant. 13:62-64.
43. Trick, W. E., S. K. Fridkin, J. R. Edwards, R. A. Hajjeh, R. P. Gaynes, et al. 2002. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin. Infect. Dis. 35:627-630.
44. Tucker, W. S., B. B. Snell, D. P. Island, and C. R. Gregg. 1985. Reversible adrenal insufficiency induced by ketoconazole. JAMA 253:2413-2414.
45. Varis, T., K. T. Kivistö, J. T. Backman, and P. J. Neuvonen. 1999. Itraconazole decreases the clearance and enhances the effects of intravenously administered methylprednisolone in healthy volunteers. Pharmacol. Toxicol. 85:29-32.
46. Wagner, R. L., P. F. White, P. B. Kan, M. H. Rosenthal, and D. Feldman. 1984. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N. Engl. J. Med. 310:1415-1421.
47. White, M. C., and P. Kendall-Taylor. 1985. Adrenal hypofunction in patients taking ketoconazole. Lancet 1:44-45.
48. Winston, D. J., A. Pakrasi, and R. W. Busuttil. 1999. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 131:729-737.
49. Zeger, S. L., and K. Y. Liang. 1992. An overview of methods for the analysis of longitudinal data. Stat. Med. 11:1825-1839.